U.S. Markets open in 4 hrs 12 mins

Y-mAbs Therapeutics, Inc. (YMAB)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
34.20+5.55 (+19.37%)
At close: 4:00PM EDT
Currency in USD
Earnings EstimateCurrent Qtr. (Mar 2021)Next Qtr. (Jun 2021)Current Year (2021)Next Year (2022)
No. of Analysts7798
Avg. Estimate0.19-0.78-1.74-1.81
Low Estimate-0.99-0.98-2.85-2.69
High Estimate0.75-0.570.52-1
Year Ago EPS-0.66-1.01-2.97-1.74
Revenue EstimateCurrent Qtr. (Mar 2021)Next Qtr. (Jun 2021)Current Year (2021)Next Year (2022)
No. of Analysts67109
Avg. Estimate44.47M6.08M81.31M99.65M
Low Estimate1M3M17M60M
High Estimate72.52M11.78M188.32M145.5M
Year Ago SalesN/AN/A20.75M81.31M
Sales Growth (year/est)N/AN/A291.90%22.60%
Earnings History3/30/20206/29/20209/29/202012/30/2020
EPS Est.-0.62-0.68-0.78-0.51
EPS Actual-0.66-1.01-0.82-0.48
Difference-0.04-0.33-0.040.03
Surprise %-6.50%-48.50%-5.10%5.90%
EPS TrendCurrent Qtr. (Mar 2021)Next Qtr. (Jun 2021)Current Year (2021)Next Year (2022)
Current Estimate0.19-0.78-1.74-1.81
7 Days Ago0.19-0.78-1.74-1.83
30 Days Ago0.19-0.77-1.72-1.78
60 Days Ago0.15-0.74-1.62-1.65
90 Days Ago-0.07-0.77-1.69-1.94
EPS RevisionsCurrent Qtr. (Mar 2021)Next Qtr. (Jun 2021)Current Year (2021)Next Year (2022)
Up Last 7 DaysN/AN/AN/A1
Up Last 30 DaysN/AN/AN/A2
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesYMABIndustrySector(s)S&P 500
Current Qtr.128.80%N/AN/AN/A
Next Qtr.22.80%N/AN/AN/A
Current Year41.40%N/AN/AN/A
Next Year-4.00%N/AN/AN/A
Next 5 Years (per annum)-88.60%N/AN/AN/A
Past 5 Years (per annum)N/AN/AN/AN/A